Status:

COMPLETED

A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants

Lead Sponsor:

Hoffmann-La Roche

Conditions:

Healthy Volunteers

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to investigate the effect of multiple oral doses of itraconazole on the pharmacokinetics of RO7017773 in healthy volunteers.

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Healthy (absence of evidence of any active or chronic disease following a detailed medical and surgical history, a complete physical examination including vital signs, 12-lead ECG, hematology, blood chemistry, serology and urinalysis) as judged by the Investigator.
  • Male and women of non-childbearing potential (WONCBP)
  • Exclusion Criteria
  • History of convulsions (other than benign febrile convulsions of childhood) including epilepsy, or personal history of significant cerebral trauma or central nervous system (CNS) infections (e.g., meningitis)
  • History of clinically significant hypersensitivity or allergic reactions
  • Abnormal blood pressure
  • Abnormal pulse rate
  • History or presence of clinically significant ECG abnormalities before study drug administration or cardiovascular disease
  • Current or chronic history of liver disease, or known hepatic or biliary abnormalities
  • Positive test for drugs of abuse or alcohol
  • Evidence of human immunodeficiency virus (HIV) infection
  • Presence of hepatitis B surface antigen (HBsAg) or positive HCV antibody test result at screening or within 3 months prior to starting study treatment
  • Participants who regularly smoke more than 5 cigarettes daily or the equivalent and are unable or unwilling not to smoke during the in-house period

Exclusion

    Key Trial Info

    Start Date :

    December 17 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 14 2019

    Estimated Enrollment :

    14 Patients enrolled

    Trial Details

    Trial ID

    NCT03774576

    Start Date

    December 17 2018

    End Date

    March 14 2019

    Last Update

    May 7 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    BIOTRIAL

    Rennes, France, 35042

    A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants | DecenTrialz